Prelude Capital Management’s Krystal Biotech KRYS Stock Holding History

Prelude Capital Management’s Portfolio KRYS Stock Details KRYS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$254K	Buy
2024 Q2	–	Sell
2024 Q1	$605K	Buy
2018 Q3	–	Sell
2018 Q2	$1K	Buy